相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sorafenib combined with transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma: a large-scale multicenter study of 222 patients
Y. Zhao et al.
ANNALS OF ONCOLOGY (2013)
Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial
Young-Hwa Chung et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study
Wei Bai et al.
JOURNAL OF DIGESTIVE DISEASES (2013)
Transplantation for Hepatocellular Carcinoma in Younger Patients Has an Equivocal Survival Advantage as Compared With Resection
J. A. Graham et al.
TRANSPLANTATION PROCEEDINGS (2013)
The efficacy of TACE combined sorafenib in advanced stages hepatocellullar carcinoma
Xu-Dong Qu et al.
BMC CANCER (2012)
Conventional transarterial chemoembolisation in combination with sorafenib for patients with hepatocellular carcinoma: a pilot study
Wolfgang Sieghart et al.
EUROPEAN RADIOLOGY (2012)
Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
Joong-Won Park et al.
JOURNAL OF HEPATOLOGY (2012)
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial
Domenico Sansonno et al.
ONCOLOGIST (2012)
Hepatitis C virus and other risk factors in hepatocellular carcinoma
E. Schiefelbein et al.
ACTA VIROLOGICA (2012)
The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma
R. Cabrera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
J. -L. Raoul et al.
CANCER TREATMENT REVIEWS (2011)
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
Masatoshi Kudo et al.
EUROPEAN JOURNAL OF CANCER (2011)
Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma
Timothy M. Pawlik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Continuous Administration of Sorafenib in Combination with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: Results of a Phase I Study
Jean-Francois Dufour et al.
ONCOLOGIST (2010)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Evolution of systemic therapy of advanced hepatocellular carcinoma
Thomas Yau et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Treatment of hepatocellular carcinoma
Alejandro Forner et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort study of 257 patients in Toronto
I Levy et al.
GUT (2002)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
分享论文
